Diana Stempak

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

Julia Glade Bender, Peter C. Adamson, Joel M. Reid et al. · Journal of Clinical Oncology · 2008 · 251 citations

Pharmacy, Oncology, Pharmacology +16

A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report

Brigitte C. Widemann, AeRang Kim, Elizabeth Fox et al. · Clinical Cancer Research · 2012 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

High-Dose Celecoxib and Metronomic “Low-dose” Cyclophosphamide Is an Effective and Safe Therapy in Patients with Relapsed and Refractory Aggressive Histology Non–Hodgkin's Lymphoma

Rena Buckstein, Robert S. Kerbel, Yuval Shaked et al. · Clinical Cancer Research · 2006 · 111 citations

Medicine, Pharmacology, Pharmacotherapy +16

Oral Versus High-Dose Pulse Corticosteroids for Problematic Infantile Hemangiomas: A Randomized, Controlled Trial

Elena Pope, Bernice R. Krafchik, Colin Macarthur et al. · PEDIATRICS · 2007 · 111 citations

Pharmacy, Pediatrics, Pharmacotherapy +14

Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours

Sylvain Baruchel, Manuel Diezi, Darren Hargrave et al. · European Journal of Cancer · 2006 · 89 citations

Medicine, Pharmacokinetics, Pharmacology +14